Biopharmaceutical Third Party Logistics (3PL) Market, By Supply Chain (Cold Chain, Non-Cold Chain), By Region (North America, Europe, Asia Pacific, Middle East & Africa, And South America) – Market Size & Forecasting To 2028

Biopharmaceutical Third Party Logistics is the transportation of pharmaceutical products from one place to another using advanced vehicles. Pharmaceutical products are temperature sensitive and require continuous monitoring therefore technically advanced vehicles are used for transportation of these products. For effective distribution and maintaining efficacy pharmaceutical companies prefer this kind of transportation.

The Biopharmaceutical Third-Party Logistics market is driven by various factors such as an increase in demand for advance logistics service in the industry, growing investment in R&D for development of advance services, also a technological advancement that helps to manage temperature and other facilities in logistics service are factors that majorly drive the market. Moreover, the development of advanced vehicles for transportation with effective facilities, a growing trend in logistics outsourcing is anticipated to propel the market growth.

Furthermore, an increase in demand for pharmaceutical products industries has increases outsourcing, multiple pharmaceutical companies are entering into an agreement or are outsourcing to 3PL service providers to reduce the overall operating cost, development of various apps for monitoring are some of the factors that fuel the market growth. Also, rising demand for biologics owing to the growing prevalence of chronic diseases is contributing well to biopharmaceutical third-party logistics (3PL) industry growth, and initiative taken by various industries for capturing data using mobile apps is expected to drive the market.

Segmentation

The Biopharmaceutical Third Party Logistics market segmentation is based on supply chain and region.

Supply Chain Outlook

Based on supply chain the market is segmented into Cold Chain, Non-Cold Chain. Non-cold chain logistics is anticipated to hold maximum market share because it does not require temperature controller and other facilities for transportation like biologics. Third party logistics services provide higher visibility, reduces overall operating cost, and helps to develop a stronger logistics network with higher returns and lower risks.

Cold chain logistics are expected to fasted growing segment in forecast period owing to increase in development of new biologics, occurrence of different types of precision medicine inventions, has projected to grow demand for cold chain logistics.

Region Outlook

Based on region the biopharmaceutical third party logistics market is segmented into North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. North America region is anticipated to dominate market owing to growing in import and export of biopharmaceuticals, increasing disposable income, presence of major pharmaceutical companies in this region and most of those are depend on third party logistics is expected to drive the growth of this region. Furthermore, Asia Pacific region is projected to witness relative growth in coming years owing to presence of generic drugs, adoption of advance technologies, rise in demand of medicine by geriatric population is expected to grow the market.

Market Players

The key leading players in biopharmaceutical third party logistics includes United Parcel Service of America, Inc, Kerry logistics network limited, DB Schenker, Agility, SF Express, Kuehne and Nagel, AmerisourceBergen Corporation, DHL International GmbH.

What Does This Report Provide?

This report provides a detailed understanding of the global bio-pharmaceutical third-party logistics market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Supply Chain

  • Cold Chain
  • Non-Cold Chain

By Region:

  • North America Acetone Market
    • By Country (US, Canada, Mexico)
    • By Supply Chain
  • Western Europe Acetone Market
    • By Country (Germany, Russia, UK, France, Italy, Spain, Rest of Western Europe)
    • By Supply Chain
  • Asia Pacific Acetone Market
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Supply Chain
  • Middle East & Africa Acetone Market
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
    • By Supply Chain
  • South America Acetone Market
    • By Country (Brazil, Argentina, Colombia, Rest of South America)
    • By Supply Chain

Reasons to Buy This Report:

  • Market size estimation of thebio-pharmaceutical third-party logistics market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com